SCHEMBL610935

SCHEMBL610935

CCC(C(=O)C=Cc1cc(F)ccc1OC)C(=O)C=Cc1cc(F)ccc1OC

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.49
AR P10275 1/20 0.48
JUN P05412 1/20 0.48
NFKB1 P19838 1/20 0.48
NFE2L2 Q16236 4/20 0.46
RELA Q04206 2/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
TFEB P19484 1/20 0.44
CAPN1 P07384 1/20 0.44
KDM4E B2RXH2 2/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL610934 1.00 BACE1 (0.49) BACE1ARJUNNFKB1NFE2L2
SCHEMBL16815421 0.79 KDM4E (0.57) BACE1ARJUNNFKB1NFE2L2
SCHEMBL7689315 0.79 KDM4E (0.68) BACE1ARJUNNFKB1NFE2L2
SCHEMBL16815420 0.79 KDM4E (0.57) BACE1ARJUNNFKB1NFE2L2
SCHEMBL7689317 0.79 KDM4E (0.68) BACE1ARJUNNFKB1NFE2L2
SCHEMBL2690713 0.79 FDPS (0.56) BACE1ARJUNNFKB1NFE2L2
SCHEMBL5574666 0.79 FDPS (0.56) BACE1ARJUNNFKB1NFE2L2
SCHEMBL9974139 0.77 NFE2L2 (0.66) NFE2L2ABCG2KDM4E
SCHEMBL10061355 0.75 BACE1 (0.46) BACE1ARJUNNFKB1NFE2L2
SCHEMBL609838 0.75 BACE1 (0.59) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11596716-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2023-03-07 US disclosed
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2021-05-13 US disclosed
US-10874766-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2020-12-29 US disclosed
EP-3038621-B1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RES INSTITUTE (US) 2020-12-02 EP disclosed
EP-3038621-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR Human Biomolecular Research Institute (US) 2016-07-06 EP disclosed
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2016-02-11 US disclosed
WO-2014146039-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2014-09-18 WO disclosed
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2012-02-16 US disclosed
WO-2010068935-A2 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10874766-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 BACE1 1942/4885AR 4082/4885JUN 2257/4885
US-11596716-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 BACE1 2083/4885AR 3810/4885JUN 1770/4885
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 BACE1 2083/4885AR 3810/4885JUN 1770/4885
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 BACE1 2700/4885AR 4258/4885JUN 2775/4885
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE L1CAM, LY96, GMFG BACE1 435/4885AR 4674/4885JUN 4222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.